--- title: "SANERGY GROUP released its interim results, with a loss attributable to shareholders of USD 9.664 million, narrowing by 32.74% year-on-year" type: "News" locale: "en" url: "https://longbridge.com/en/news/255203334.md" description: "According to the Zhitong Finance APP, SANERGY GROUP released its performance for the six months ending June 30, 2025. The group achieved revenue of USD 23.776 million during the period, a year-on-year decrease of 25.93%; the loss attributable to shareholders was USD 9.664 million, a year-on-year narrowing of 32.74%; the basic loss per share was 0.7 cents" datetime: "2025-08-29T12:18:02.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/255203334.md) - [en](https://longbridge.com/en/news/255203334.md) - [zh-HK](https://longbridge.com/zh-HK/news/255203334.md) generator: "portal-rs" --- # SANERGY GROUP released its interim results, with a loss attributable to shareholders of USD 9.664 million, narrowing by 32.74% year-on-year According to the Zhitong Finance APP, SANERGY GROUP (02459) announced its results for the six months ending June 30, 2025. During the period, the group achieved revenue of USD 23.776 million, a year-on-year decrease of 25.93%; the loss attributable to shareholders was USD 9.664 million, a year-on-year narrowing of 32.74%; basic loss per share was 0.7 cents ### Related Stocks - [02459.HK](https://longbridge.com/en/quote/02459.HK.md) ## Related News & Research - [BREAKINGVIEWS-Fosun's ClubMed spinoff looks a hard sell](https://longbridge.com/en/news/297983421.md) - [Jensen Huang: Nvidia’s Vera Rubin Platform Turns Electricity Into a $40 Billion Cash Machine](https://longbridge.com/en/news/297688917.md) - [Fosun Trims Indian Pharma Stake While Retaining Control](https://longbridge.com/en/news/298132819.md) - [4-Oil prices rise on escalation in Middle East](https://longbridge.com/en/news/297926451.md) - [US crude stocks fall on strong refining activity and exports, EIA says](https://longbridge.com/en/news/297807484.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**